Pharmacogenetics has evolved over the past few years into pharmacogenomics, shifting focus from individual candidate genes to genome-wide association studies. The latest installment in our Genomic Medicine series, Genomics and Drug Response, reviews recent pharmacogenetic and pharmacogenomic advances, and discusses how such advances are reflected in drug labels. The authors aim to provide assurance that advances resulting from the application of genomic science to drug therapy may assist with drug selection and dosing, and reduce the odds of adverse drug reactions. Earlier articles in this series include Genomics and the Continuum of Cancer Care — NEJM, Genomics, Type 2 Diabetes, and Obesity, Ancestry and Disease in the Age of Genomic Medicine, New Therapeutic Approaches to Mendelian Disorders, Genomewide Association Studies and Assessment of the Risk of Disease, Genomic Medicine — An Updated Primer.
Posted by Karen Buckley • April 6th, 2011
Comments are closed.
Get Our Blog Updates Via E-mail!
NEJM in the News
- HealthDay/Physician’s Briefing and Medscape covered the NEJM Original Article, “Hypothermia for Intracranial Hypertension after Traumatic Brain Injury” (10/7). (October 8)
- Medscape covered the NEJM Perspective, “Specialty Pharmaceuticals for Hyperlipidemia — Impact on Insurance Premiums.” (October 8)
- Fox News/Reuters referenced the NEJM Original Article, “PD-1 Blockade in Tumors with Mismatch-Repair Deficiency,” in an article titled, “Nobel discoveries on DNA repair now fueling cancer drug research.” (October 8)
- Medical Daily covered the NEJM Original Article, “Hypothermia for Intracranial Hypertension after Traumatic Brain Injury.” (October 7)
- The Huffington Post referenced the NEJM Original Articles, “Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer” and “Prospective Validation of a 21-Gene Expression Assay in Breast Cancer,” and the editorial, “Biology before Anatomy in Early Breast Cancer — Precisely the Point,” in a story about breast cancer advancements. (October 07)
- Tech Times covered the NEJM Original Article, “Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.” (October 07)
NEJM on Youtube
- NEJM Group will be exhibiting at the upcoming conferences below:
- European Society of Cardiology in London, England. Aug. 29-Sept. 2. Booth #C-807
- IDWeek in San Diego, CA. Oct. 8-10. Booth #922
- American Society of Nephrology in San Diego, CA. Nov. 5-7. Booth #508
- American Heart Association in Orlando, FL. Nov. 8-10. Booth #822
- American Society of Hematology in Orlando, FL. Dec. 5-7. Booth #514
Tagsabdominal pain anemia asthma breast cancer cardiac arrest Case Records Case Records of the Massachusetts General Hospital Clinical Decisions Clinical Practice Clinical Problem-Solving colorectal cancer COPD CPR Diabetes dyspnea fever global health glucocorticoids HIV hypertension Interactive Medical Cases Massachusetts General Hospital medicine Medstro myocardial infarction NEJM nejm 200th anniversary NEJM 200th Anniversary website NEJM Group NEJM Group Open Forum New England Journal of Medicine obesity pregnancy prostate cancer Quick Take ribavirin sepsis septic shock smoking stroke thrombocytopenia tuberculosis type 2 diabetes Venous thromboembolism weight loss